Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
GOSS
#3275
Gossamer Bio, Inc. Common Stock
0.4
2
+7.69%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+7.69%
Changement Mensuel
-84.33%
Evolution sur 6 mois
-83.00%
Changement Annuel
-63.16%
Clôture Précédente
0.3
9
Open
0.4
2
Bid
Ask
Low
0.4
2
High
0.4
3
Volume
101
Marchés
Actions des Marchés US
Soins de Santé
GOSS
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
75.53 M
76.48 M
94.98 M
225.58 M
227.22 M
—
Valuation ratios
Enterprise value
244.3 M
681.55 M
81.8 M
186.71 M
159.47 M
1.23 B
Price to earnings ratio
—
-3.61
-0.75
-0.82
-3.62
-14.5
Price to sales ratio
—
—
—
203.92
1.78
24.25
Price to cash flow ratio
—
-4.48
-0.92
-0.93
-59.01
-37.89
Price to book ratio
—
6.97
14.29
2.36
6.94
11.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.45
0.68
0.84
0.58
0.18
0.63
Return on equity %
0.76
1.93
18.99
2.86
1.92
8.4
Return on invested capital %
3 387.39
2 497.3
2 002.56
2 122.48
844.13
—
Gross margin %
100
—
—
100
100
400
Operating margin %
91.39 K
—
—
25.31 K
52.24
353.57
EBITDA margin %
—
—
—
—
—
—
Net margin %
95.06 K
—
—
24.77 K
49.28
1 418.51
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
13.51
8.32
5.32
5.94
6.88
20.28
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0.37
0.16
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.05
0.08
0.04
0
0
—
Long term debt to total equity ratio
0.09
0.24
0.99
0.01
0
—
Per share metrics
Operating cash flow per share
—
2.52
2.21
1.04
0.02
0.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
4.35
3.02
1.94
1.3
6.75
Net current asset value per share
—
4.43
3.1
2.01
1.37
4.52
Tangible book value per share
—
1.62
0.14
0.41
0.13
0.72
Working capital per share
—
3.9
2.51
1.67
1.17
3.6
Book value per share
—
1.62
0.14
0.41
0.13
0.72
Nouvelles
Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates
Wedbush dégrade l’action Gossamer Bio après les résultats d’essai
Gossamer Bio stock downgraded by Wedbush on trial results
Barclays abaisse la note de Gossamer Bio après les résultats d’essai
Barclays cuts Gossamer Bio stock rating on trial results
Leerink abaisse la note de Gossamer Bio après l’échec de l’essai
Leerink cuts Gossamer Bio stock rating on trial miss
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%
Tesla, Oracle among market cap stock movers on Monday
American Express, Oracle among market cap stock movers on Monday